Incyte Corporation (INCY) July 20, 2021 Stock Price, Analysis & Forecast
Incyte Corporation (NASDAQ: INCY) opened the trading session on July 20, 2021, at $78.46, exposing a change of 2.1274% versus the previous close at $77.56. Within the trading session, the stock price jumped to $79.29 and sunk to $78. Finally, the stock harmonized at $79.21. Yet, bearing in mind a longer-term approach, Incyte Corporation reported a 52 Week Range within $75.52-$107.09.
Incyte Corporation's shares outstanding currently worth $219.92M, in addition to a float of $186.17M. INCY operates in the TRADE & SERVICES sector of the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry and has a market capitalization of $17.42B (as of July 20, 2021). It should be stressed that Incyte Corporation's 50-day Moving Average harmonized at $83.23, while such sign as 200-day Moving Average is at the present time $84.07.
To define the company's efficiency, let's take a look at Incyte Corporation's conglomerate performance. To date, INCY has full-time employees. Incyte Corporation has generated $inf per worker Within the last fiscal year. At the same time, INCY's income per employee was $inf. And now, let's take a look at the company's income report. Incyte Corporation's Net Income for the last fiscal year was $-295,697,000, while such sign as Income Before Taxes was at the level of $-232,218,000. INCY's Operating Income was at the mark of $-263,676,000.
Incyte Corporation (INCY) Earnings & Revenue
Talking about the Profitability, INCY reached a Profit Margin of 17.7% and an Operating Margin (TTM) of 19.3%. However, when we touch the questions of management effectiveness, Incyte Corporation generated a Return on Equity (TTM) of 20.5% and a Return on Assets (TTM) of 10.1%. A bit more income statements might bring clarity to our overview. According to the results of the latest quarter ended March 31, 2021, Incyte Corporation generated Revenue (TTM) of $2.70B, reporting a Quarterly Revenue Growth of 6.4%. As for the Revenue Per Share (TTM), this indicator was at the mark of $12.35. The company's Gross Profit (TTM) was $276.63M, while according to the EBITDA report, it was estimated at $574.99M.
Incyte Corporation (NASDAQ: INCY) Owners & Shares
Finally, let's take a look at the share statistics. As mentioned above, INCY's shares outstanding now amounts to $219.92M, where Shares Short was $5.56M versus the prior month amounted to $5.16M. (Short % of Float was 2.99%). And now, let's overview which kind of investors works with Incyte Corporation's stocks. INCY's current ownership accounts for 93.9% institutional investors, while 1.46% of shares belong to the insiders. Also worth mentioning some indicators affecting dividends & splits. Thus, INCY's Forward Annual Dividend Rate is currently at the mark of 0, whereas the Dividend Yield is 0%, and a Dividend Payout Ratio is 0% (Dividend Date: December 31, 1969). The company's Dividend Per Share sign thereby is $None.
INCY Trading Performance
It's time to observe the current performance indicators for Incyte Corporation. INCY's price/earnings to growth ratio during the last reported quarter was 0.91%. The company's PE Ratio stands at 36.32%, while INCY's Beta score is 0.797. Also worth noting that Incyte Corporation's Diluted EPS (Earnings per Share) trailing twelve months is at the mark of 2.181. Other valuable indicators are Price To Sales Ratio (TTM), which is currently recorded at 6.29, as well as Price To Book Ratio, which amounts to 6.25.
Incyte Corporation Analysis & Estimates
Within the previous 9-day period, Incyte Corporation's Average True Range (ATR) was 1.8268, while the stock's Stochastic SlowD moving average was 21.1107%, and the SlowK moving average volumed at 21.1107%.